Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RNF216 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BBIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF324 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF9B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NASP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC150 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2CB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RTCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LGALS8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DRG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCLRE1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAAA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TM2D2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on